The Latest Breaking News from Ulcerative Colitis

Nearly Three in Four Women with Crohn's or Colitis Conceived After Fertility Treatment in Early WIsDoM Registry Data

Nearly three in four women with Crohn's or colitis who tried fertility treatment conceived in early WIsDoM data presented at ACG 2026 in Nashville.

Medical Daily · Oct 16

UCLA and Mount Sinai Begin a $4 Million NIH Study on Why Colitis Symptoms Persist After Inflammation Heals

UCLA and Mount Sinai will study why about 1 in 3 ulcerative colitis patients keep IBS-like symptoms after inflammation heals, with a $4M NIH grant.

Medical Daily · Oct 7

Children as Young as Two with Ulcerative Colitis Can Now Get Stelara After an FDA Label Expansion

FDA cleared Stelara for pediatric ulcerative colitis in children 2 and older. Here is what the trial showed and what families should ask.

Medical Daily · Sep 2

Big Lalas Energy to ulcerative colitis meds: Fox is this World Cup’s very soul in the US

The US version of the tournament’s opening ceremony helpfully focused on one of its main themes: aspirational consumerism

The Guardian - US · Jun 13

Los Angeles woman suffers bathroom emergency at Hollywood party: ‘Abandoned my underwear’

The Tinkerbell costume didn't help.

We Got This Covered · May 27

'My body said stop' – 24-year-old pro cyclist forced to retire amid health struggle

Uno-X Mobility's Anne Dorthe Ysland has been battling ulcerative colitis since 2022

Cycling Weekly · May 5

Ulcerative Colitis Treatment Guide: 5-ASA Therapy, Biologics & Long-Term Remission

Ulcerative colitis control guide covering 5-ASA therapy, biologics, flare treatment, and mucosal healing for long-term remission and reduced colon inflammation.

Medical Daily · Apr 13

Crohn's vs. Ulcerative Colitis: Understanding IBD Symptoms, Causes & Treatment

Discover what sets Crohn's disease apart from ulcerative colitis. Explore IBD symptoms, how doctors diagnose these conditions, and effective treatment strategies.

Medical Daily · Jan 26

AnaptysBio To Save $10 Million After Discontinuing Ulcerative Colitis Study

AnaptysBio Inc. (NASDAQ:ANAB) on Monday released data from the Phase 2 trial of rosnilimab for moderate-to-severe ulcerative colitis.

Benzinga · Nov 10, 2025

FDA Expands Johnson & Johnson Ulcerative Colitis Drug Approval To Pediatric Patients

On Tuesday, the U.S. Food and Drug Administration (FDA) approved Johnson Johnson’s (NYSE:JNJ) Simponi (golimumab) for children with moderately to severely active ulcerative colitis (UC) who weigh at least 15 kg.

Benzinga · Oct 8, 2025